2004/C 24/06 Note for guidance on minimising the risk of transmitting animal spongiform encephalopathyagents via human and veterinary medicinal products (EMEA/410/01 Rev. 2 - October 2003) adopted by the Committee for Proprietary Medicinal Products (CPMP)
Title:
2004/C 24/06 Note for guidance on minimising the risk of transmitting animal spongiform encephalopathyagents via human and veterinary medicinal products (EMEA/410/01 Rev. 2 - October 2003) adopted by the Committee for Proprietary Medicinal Products (CPMP)
Short Title:
2004/C 24/06
Origin/Publisher:
European Commission
Document Type:
Note for guidance
Content:
This revision of the TSE (Transmissible Spongiform Encephalopathy) note for guidance has been
undertaken to introduce, inter alia, risk assessment into the regulatory compliance process, to provide
clarification on a variety of terms and classifications, and to take into account advances in scientific
knowledge, Community legislation and rules affecting the authorisation of medicinal products for
human or veterinary use.